Clopidogrel Impurity 49 | CAS 17447-35-7 - Request Quote
Clopidogrel Impurity 49
| SZ CAT No: | SZ-C044100 |
| CAS No | 17447-35-7 |
| Mol.F. | C10H10ClNO5 |
| Mol.Wt. | 259.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Clopidogrel Impurity 49 is chemically (2R,3R)-4-((4-chlorophenyl)amino)-2,3-dihydroxy-4-oxobutanoic acid. Clopidogrel Impurity 49 is supplied with detailed characterization data compliant with regulatory guideline. Clopidogrel Impurity 49 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Clopidogrel.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 17447-35-7
Purchase 17447-35-7
Order 17447-35-7
Enquire 17447-35-7
price of 17447-35-7
17447-35-7 Supplier
17447-35-7 Manufacturer
17447-35-7 Exporter
buy high quality Clopidogrel Impurity 49
Purchase Clopidogrel Impurity 49
Clopidogrel Impurity 49 suppliers
Clopidogrel Impurity 49 manufacturers
Clopidogrel Impurity 49 price
Order Clopidogrel Impurity 49
Enquire Clopidogrel Impurity 49
Clopidogrel Impurity 49 cost
Clopidogrel Impurity 49 Supplier
Clopidogrel Impurity 49 Distributor
Clopidogrel Impurity 49 for Method Validation
Clopidogrel Reference Standard
Clopidogrel Impurity 49 for ANDA Filing
Clopidogrel Impurity 49 for Forced Degradation Studies
Clopidogrel Impurity 49 Identification Standards
Clopidogrel Impurity 49 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.